$BMTI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMIMETIC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIOMIMETIC THERAPEUTICS, INC.. Get notifications about new insider transactions in BIOMIMETIC THERAPEUTICS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 08 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Option Exercise | M | 2.87 | 6,000 | 17,220 | 0 | |
Apr 08 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Buy | M | 3.47 | 34,875 | 121,016 | 56,875 | 22 K to 56.9 K (+158.52 %) |
Apr 08 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Buy | M | 3.47 | 6,000 | 20,820 | 22,000 | 16 K to 22 K (+37.50 %) |
Apr 08 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Buy | M | 2.87 | 6,000 | 17,220 | 16,000 | 10 K to 16 K (+60.00 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Buy | P | 9.24 | 75 | 693 | 1,075 | 1,000 to 1.1 K (+7.50 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Buy | P | 9.25 | 1,000 | 9,245 | 1,000 | 0 to 1,000 |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Buy | P | 8.99 | 8,500 | 76,446 | 9,300 | 800 to 9.3 K (+1,062.50 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 8.99 | 419 | 3,767 | 1,186,561 | 1.2 M to 1.2 M (+0.04 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 9.00 | 1,731 | 15,579 | 1,186,142 | 1.2 M to 1.2 M (+0.15 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 8.90 | 30 | 267 | 1,184,411 | 1.2 M to 1.2 M (0.00 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 8.93 | 2,720 | 24,290 | 1,184,381 | 1.2 M to 1.2 M (+0.23 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 8.86 | 400 | 3,544 | 1,181,661 | 1.2 M to 1.2 M (+0.03 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 8.91 | 100 | 891 | 1,181,261 | 1.2 M to 1.2 M (+0.01 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Buy | P | 8.40 | 5,000 | 42,000 | 8,000 | 3 K to 8 K (+166.67 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Buy | P | 9.05 | 1,000 | 9,050 | 6,493 | 5.5 K to 6.5 K (+18.20 %) |
Apr 01 2008 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 9.00 | 10,000 | 90,000 | 22,135 | 12.1 K to 22.1 K (+82.41 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 3.47 | 563 | 1,954 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 563 | 1,616 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 563 | 1,616 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 1,125 | 3,229 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 1,125 | 3,229 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 1,125 | 3,229 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 1,125 | 3,229 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 563 | 1,616 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 563 | 1,616 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 1,125 | 3,229 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 563 | 1,616 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 563 | 1,616 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 563 | 1,616 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | M | 2.87 | 1,125 | 3,229 | 0 | |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 3.47 | 563 | 1,954 | 38,250 | 37.7 K to 38.3 K (+1.49 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 563 | 1,616 | 37,688 | 37.1 K to 37.7 K (+1.52 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 563 | 1,616 | 37,125 | 36.6 K to 37.1 K (+1.54 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 1,125 | 3,229 | 36,563 | 35.4 K to 36.6 K (+3.17 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 1,125 | 3,229 | 35,438 | 34.3 K to 35.4 K (+3.28 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 1,125 | 3,229 | 34,313 | 33.2 K to 34.3 K (+3.39 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 1,125 | 3,229 | 33,188 | 32.1 K to 33.2 K (+3.51 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 563 | 1,616 | 32,063 | 31.5 K to 32.1 K (+1.79 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 563 | 1,616 | 31,500 | 30.9 K to 31.5 K (+1.82 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 1,125 | 3,229 | 30,938 | 29.8 K to 30.9 K (+3.77 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 563 | 1,616 | 29,813 | 29.3 K to 29.8 K (+1.92 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 563 | 1,616 | 29,250 | 28.7 K to 29.3 K (+1.96 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 563 | 1,616 | 28,688 | 28.1 K to 28.7 K (+2.00 %) |
Mar 31 2008 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Buy | M | 2.87 | 11,250 | 32,288 | 28,125 | 16.9 K to 28.1 K (+66.67 %) |
Feb 29 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | A | 13.88 | 205,703 | 2,855,158 | 205,703 | |
Feb 25 2008 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | A | 14.41 | 45,000 | 648,450 | 45,000 | |
Feb 25 2008 | BMTI | BIOMIMETIC THERAPE ... | Hirsch Steven Neal | COO & Executive VP | Option Exercise | A | 14.41 | 30,000 | 432,300 | 30,000 | |
Feb 25 2008 | BMTI | BIOMIMETIC THERAPE ... | Hart Charles Edward | Chief Scientific Of ... | Option Exercise | A | 14.41 | 20,000 | 288,200 | 20,000 | |
Feb 25 2008 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Option Exercise | A | 14.41 | 25,000 | 360,250 | 25,000 | |
Feb 25 2008 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 14.41 | 25,000 | 360,250 | 25,000 | |
Feb 25 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Option Exercise | A | 14.41 | 15,000 | 216,150 | 15,000 | |
Feb 25 2008 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | A | 14.41 | 10,000 | 144,100 | 10,000 | |
Feb 25 2008 | BMTI | BIOMIMETIC THERAPE ... | Pagano Russell P. | VP, Reg. & Clinical ... | Option Exercise | A | 17.95 | 100,000 | 1,795,000 | 100,000 | |
Jan 24 2008 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Buy | P | 15.19 | 300 | 4,557 | 5,493 | 5.2 K to 5.5 K (+5.78 %) |
Jan 24 2008 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Buy | P | 15.20 | 200 | 3,040 | 5,193 | 5 K to 5.2 K (+4.01 %) |
Jan 24 2008 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Buy | P | 15.26 | 100 | 1,526 | 4,993 | 4.9 K to 5 K (+2.04 %) |
Jan 24 2008 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Buy | P | 15.30 | 2,900 | 44,370 | 4,893 | 2 K to 4.9 K (+145.51 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 17.07 | 1,611 | 27,500 | 10,000 | 11.6 K to 10 K (-13.87 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 17.06 | 964 | 16,446 | 11,611 | 12.6 K to 11.6 K (-7.67 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 17.05 | 2,036 | 34,714 | 12,575 | 14.6 K to 12.6 K (-13.93 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 16.97 | 820 | 13,915 | 14,611 | 15.4 K to 14.6 K (-5.31 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 16.95 | 2,442 | 41,392 | 15,431 | 17.9 K to 15.4 K (-13.66 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 16.94 | 1,900 | 32,186 | 17,873 | 19.8 K to 17.9 K (-9.61 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 16.93 | 100 | 1,693 | 19,773 | 19.9 K to 19.8 K (-0.50 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 16.92 | 2,000 | 33,840 | 19,873 | 21.9 K to 19.9 K (-9.14 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 16.91 | 517 | 8,742 | 21,873 | 22.4 K to 21.9 K (-2.31 %) |
Jan 02 2008 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Sell | S | 16.90 | 1,610 | 27,209 | 22,390 | 24 K to 22.4 K (-6.71 %) |
Jan 03 2008 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Gift | G | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Jan 03 2008 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Gift | G | 0.00 | 2,000 | 0 | 12,135 | 14.1 K to 12.1 K (-14.15 %) |
Dec 19 2007 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Dec 19 2007 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Grant | A | 0.00 | 3,000 | 0 | 27,000 | 24 K to 27 K (+12.50 %) |
Dec 19 2007 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | P | 15.11 | 2,400 | 36,271 | 17,161 | 14.8 K to 17.2 K (+16.26 %) |
Dec 19 2007 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | P | 14.76 | 100 | 1,476 | 14,761 | 14.7 K to 14.8 K (+0.68 %) |
Dec 19 2007 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | P | 14.93 | 2,000 | 29,854 | 14,661 | 12.7 K to 14.7 K (+15.80 %) |
Dec 19 2007 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | P | 14.90 | 2,000 | 29,801 | 12,661 | 10.7 K to 12.7 K (+18.76 %) |
Dec 19 2007 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Grant | A | 0.00 | 3,000 | 0 | 10,661 | 7.7 K to 10.7 K (+39.16 %) |
Sep 20 2007 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Gift | G | 0.00 | 200 | 0 | 200 | 0 to 200 |
Sep 11 2007 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Option Exercise | A | 16.12 | 10,000 | 161,200 | 145,000 | |
Sep 06 2007 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Option Exercise | M | 1.33 | 24,000 | 31,920 | 0 | |
Sep 06 2007 | BMTI | BIOMIMETIC THERAPE ... | Monsor James A. | VP - Operations | Buy | M | 1.33 | 24,000 | 31,920 | 24,000 | 0 to 24 K |
Jun 25 2007 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Option Exercise | A | 17.09 | 5,831 | 99,652 | 5,831 | |
Jun 25 2007 | BMTI | BIOMIMETIC THERAPE ... | Friedlaender Gary E | Director | Option Exercise | A | 17.09 | 5,831 | 99,652 | 48,987 | |
Jun 25 2007 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | A | 17.09 | 5,831 | 99,652 | 15,551 | |
Jun 25 2007 | BMTI | BIOMIMETIC THERAPE ... | WATSON DOUGLAS G | Director | Option Exercise | A | 17.09 | 5,831 | 99,652 | 36,116 | |
Jun 25 2007 | BMTI | BIOMIMETIC THERAPE ... | MURPHY JAMES G | Director | Option Exercise | A | 17.09 | 5,831 | 99,652 | 15,551 | |
Jun 25 2007 | BMTI | BIOMIMETIC THERAPE ... | FEDERICO CHARLES | Director | Option Exercise | A | 17.09 | 18,096 | 309,261 | 18,096 | |
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Option Exercise | M | 3.63 | 3,750 | 13,613 | 40,750 | ||
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Option Exercise | M | 3.63 | 7,500 | 27,225 | 44,500 | ||
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Option Exercise | M | 3.47 | 7,500 | 26,025 | 52,000 | ||
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Option Exercise | M | 2.87 | 7,500 | 21,525 | 59,500 | ||
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Option Exercise | M | 1.33 | 82,500 | 109,725 | 67,000 | ||
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Buy | M | 3.63 | 3,750 | 13,613 | 109,152 | 105.4 K to 109.2 K (+3.56 %) | |
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Buy | M | 3.63 | 7,500 | 27,225 | 105,402 | 97.9 K to 105.4 K (+7.66 %) | |
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Buy | M | 3.47 | 7,500 | 26,025 | 97,902 | 90.4 K to 97.9 K (+8.30 %) | |
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Buy | M | 2.87 | 7,500 | 21,525 | 90,402 | 82.9 K to 90.4 K (+9.05 %) | |
Jun 07 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Buy | M | 1.33 | 82,500 | 109,725 | 82,902 | 402 to 82.9 K (+20,522.39 %) | |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 738,174 | 0 | 0 | |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 196,351 | 0 | 0 | |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Option Exercise | C | 0.00 | 758,097 | 0 | 0 | |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | P | 12.46 | 335,575 | 4,180,459 | 2,371,771 | 2 M to 2.4 M (+16.48 %) |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | J | 0.00 | 343,574 | 0 | 2,036,196 | 1.7 M to 2 M (+20.30 %) |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 738,174 | 0 | 1,692,622 | 954.4 K to 1.7 M (+77.34 %) |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 196,351 | 0 | 954,448 | 758.1 K to 954.4 K (+25.90 %) |
Feb 02 2007 | BMTI | BIOMIMETIC THERAPE ... | Novo A/S | 10% Owner | Buy | C | 0.00 | 758,097 | 0 | 758,097 | 0 to 758.1 K |
Feb 14 2007 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Sell | S | 17.15 | 236,239 | 4,051,499 | 1,181,161 | 1.4 M to 1.2 M (-16.67 %) |
Jan 17 2007 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Option Exercise | A | 12.59 | 80,000 | 1,007,200 | 234,500 | |
Jan 26 2007 | BMTI | BIOMIMETIC THERAPE ... | Dyrberg Thomas | Director | Buy | P | 12.46 | 335,575 | 4,180,459 | 2,371,771 | 2 M to 2.4 M (+16.48 %) |
Jan 17 2007 | BMTI | BIOMIMETIC THERAPE ... | Hart Charles Edward | Chief Scientific Of ... | Option Exercise | A | 12.59 | 29,000 | 365,110 | 171,500 | |
Jan 17 2007 | BMTI | BIOMIMETIC THERAPE ... | Hirsch Steven Neal | COO & Executive VP | Option Exercise | A | 12.59 | 50,000 | 629,500 | 294,023 | |
Jan 17 2007 | BMTI | BIOMIMETIC THERAPE ... | Douglas Earl Martin | General Counsel | Option Exercise | A | 12.59 | 30,000 | 377,700 | 135,000 | |
Jan 17 2007 | BMTI | BIOMIMETIC THERAPE ... | Citron Mark Barry | Sr. Vice President | Option Exercise | A | 12.59 | 22,000 | 276,980 | 149,500 | |
Jan 17 2007 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 12.59 | 27,000 | 339,930 | 177,000 | |
Dec 18 2006 | BMTI | BIOMIMETIC THERAPE ... | Burrill & CO (Biotechnology GP ... | 10% Owner | Option Exercise | C | 0.00 | 444,538 | 0 | 0 | |
Dec 18 2006 | BMTI | BIOMIMETIC THERAPE ... | Burrill & CO (Biotechnology GP ... | 10% Owner | Option Exercise | C | 0.00 | 392,701 | 0 | 0 | |
Dec 18 2006 | BMTI | BIOMIMETIC THERAPE ... | Burrill & CO (Biotechnology GP ... | 10% Owner | Option Exercise | C | 0.00 | 1,516,194 | 0 | 0 | |
Dec 18 2006 | BMTI | BIOMIMETIC THERAPE ... | Burrill & CO (Biotechnology GP ... | 10% Owner | Sell | J | 0.00 | 1,908,895 | 0 | 444,538 | 2.4 M to 444.5 K (-81.11 %) |
Dec 18 2006 | BMTI | BIOMIMETIC THERAPE ... | Burrill & CO (Biotechnology GP ... | 10% Owner | Buy | C | 0.00 | 444,538 | 0 | 2,353,433 | 1.9 M to 2.4 M (+23.29 %) |
Dec 18 2006 | BMTI | BIOMIMETIC THERAPE ... | Burrill & CO (Biotechnology GP ... | 10% Owner | Buy | C | 0.00 | 392,701 | 0 | 1,908,895 | 1.5 M to 1.9 M (+25.90 %) |
Dec 18 2006 | BMTI | BIOMIMETIC THERAPE ... | Burrill & CO (Biotechnology GP ... | 10% Owner | Buy | C | 0.00 | 1,516,194 | 0 | 1,516,194 | 0 to 1.5 M |
Dec 04 2006 | BMTI | BIOMIMETIC THERAPE ... | Dyrberg Thomas | Director | Buy | J | 0.00 | 343,574 | 0 | 2,036,196 | 1.7 M to 2 M (+20.30 %) |
May 16 2006 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Buy | P | 8.00 | 1,250 | 10,000 | 1,250 | 0 to 1.3 K |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 8.00 | 5,100 | 40,800 | 1,422,500 | 1.4 M to 1.4 M (+0.36 %) |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Lynch Samuel Eugene | President and CEO | Buy | P | 8.00 | 7,400 | 59,200 | 1,417,400 | 1.4 M to 1.4 M (+0.52 %) |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Buy | P | 8.00 | 10,000 | 80,000 | 10,000 | 0 to 10 K |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Option Exercise | C | 0.00 | 7,660 | 0 | 0 | |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | PAPASAN LARRY W | Director | Buy | C | 0.00 | 7,660 | 0 | 7,660 | 0 to 7.7 K |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | HANHAM ANN | Director | Option Exercise | C | 0.00 | 444,538 | 0 | 0 | |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | HANHAM ANN | Director | Option Exercise | C | 0.00 | 392,701 | 0 | 0 | |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | HANHAM ANN | Director | Option Exercise | C | 0.00 | 1,516,194 | 0 | 0 | |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | HANHAM ANN | Director | Buy | C | 0.00 | 444,538 | 0 | 2,353,433 | 1.9 M to 2.4 M (+23.29 %) |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | HANHAM ANN | Director | Buy | C | 0.00 | 392,701 | 0 | 1,908,895 | 1.5 M to 1.9 M (+25.90 %) |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | HANHAM ANN | Director | Buy | C | 0.00 | 1,516,194 | 0 | 1,516,194 | 0 to 1.5 M |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Option Exercise | C | 0.00 | 889,076 | 0 | 0 | |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Ehrlich Christopher B | Director | Buy | C | 0.00 | 889,076 | 0 | 889,076 | 0 to 889.1 K |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Dyrberg Thomas | Director | Option Exercise | C | 0.00 | 738,174 | 0 | 0 | |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Dyrberg Thomas | Director | Option Exercise | C | 0.00 | 196,351 | 0 | 0 | |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Dyrberg Thomas | Director | Option Exercise | C | 0.00 | 758,097 | 0 | 0 | |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Dyrberg Thomas | Director | Buy | C | 0.00 | 738,174 | 0 | 1,692,622 | 954.4 K to 1.7 M (+77.34 %) |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Dyrberg Thomas | Director | Buy | C | 0.00 | 196,351 | 0 | 954,448 | 758.1 K to 954.4 K (+25.90 %) |
May 15 2006 | BMTI | BIOMIMETIC THERAPE ... | Dyrberg Thomas | Director | Buy | C | 0.00 | 758,097 | 0 | 758,097 | 0 to 758.1 K |